Form 4: Guardant Health CEO Executes Stock Sale
Statement of Changes in Beneficial Ownership
Co-CEO AmirAli Talasaz sold 50,000 shares of Guardant Health common stock via a pre-arranged 10b5-1 trading plan.
Summary
- AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., sold 50,000 shares of common stock.
- The transaction occurred on May 12, 2026, at a weighted average price of $100.32 per share.
- The shares were sold through the Talasaz and Eskandari 2017 Family Trust.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined schedule for selling stocks to avoid concerns about insider trading.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted via a pre-arranged 10b5-1 plan, which is a standard mechanism for executive financial planning.
Positives
- The sale was conducted under a pre-established Rule 10b5-1 plan, indicating the transaction was planned in advance rather than based on non-public information.
Negatives
- The sale represents a reduction in the insider's direct or indirect stake in the company.
Risks
- Insider selling can sometimes be perceived negatively by the market as a signal of management's view on the company's valuation.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling by high-level executives is a common practice for liquidity and diversification, particularly when executed through pre-planned 10b5-1 programs, and does not necessarily reflect a lack of confidence in the company's long-term prospects.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate executives to manage equity holdings while maintaining regulatory compliance.
Stakeholder Impact
- Shareholders should note the reduction in insider holdings, though the pre-planned nature of the sale mitigates concerns regarding potential negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/12/2026 | Date of the stock sale transaction. |
| 05/13/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Guardant Health, GH, Insider Trading, Form 4, AmirAli Talasaz, Stock Sale, 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.